ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
adultsslesystemiclupuserythematosustoll
systemic lupus erythematosus, toll-like receptor 7, toll-like receptor 8, willow, adults, sle, cle, lupus, discoid lupus erythematosus, subacute cutaneous lupus erythematosus, m5049, enpatoran
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 872805
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.